Skip to main content

Table 5 Univariate and multivariate analysis of progression-free survivals and overall survivals

From: The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer

 

Progression-free survival

Overall survival

Univariate

Multivariate

Univariate

Multivariate

Variables

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

Lymphovascular invasion

Present

2.392 (1.189–4.809)

0.014

1.242 (0.558- 2.763)

0.596

2.738 (1.013–7.405)

0.047

1.308 (0.429–3.990)

0.637

Absent

1

 

1

 

1

 

1

 

Lymph node metastasis

Present

2.399 (1.207–4.747)

0.012

1.715 (0.616- 4.476)

0.302

5.137 (1.804–14.613)

0.002

3.545 (0.948–13.251)

0.060

Absent

1

 

1

 

1

 

1

 

Anatomic stage

III

3.163 (1.551–6.560)

0.002

1.305 (0.407- 4.188)

0.654

4.631 (1.784–12.022)

0.002

1.740 (0.482–6.289)

0.398

I&II

1

 

1

 

1

 

1

 

TCIS

High

0.305 (0.154–0.605)

0.001

0.381 (0.178–0.812)

0.012

0.505 (0.162–1.330)

0.167

  

Low

1

 

1

 

1

   

ICIS

High

0.304 (0.154–0.602)

0.001

0.303 (0.150–0.615)

0.001

0.235 (0.089–0.616)

0.003

0.229 (0.086–0.609)

0.003

Low

1

 

1

 

1

   
  1. P values in bold indicate statistical significance (p < 0.05). HR, hazard ratio; CI, confidence interval; TCIS, tumor cells combined immune score; ICIS, immune cells combined immune score